Asthma

Patient recruitment

We support Asthma trials that help patients lead active lives

Asthma is a global condition affecting approximately 300,000 million individuals worldwide – with cases expected to increase another 100 million by 2025. Although there is currently no cure for asthma, symptoms can be managed by avoiding triggers and through various treatments options. However, severe asthma can be potentially life-threatening and is more difficult to treat and manage.

Clinical trials can help patients with asthma lead a more normal and active life. We’ve performed asthma patient recruitment for 30+ international trials, from Phase I to Phase III – we know how to find the right candidates for your study.

Want to discuss how we can help your asthma study?

Contact Us

Our targeting techniques

From children to adults – we have four ways of targeting for patient recruitment.

Location & capacity targeting

Patients living within a predesignated radius around active sites are targeted with ads that are activated and deactivated based on site referral volume.

Interest-based targeting

Patients searching or engaging (e.g., likes, shares, comments, etc.) with asthma-related content are targeted with social media outreach.

Demographic targeting

Gender, age, and other demographic indicators are used as filters to find patients that fit your exact criteria, with these aspects included in each and every one of our screeners.

Behavioral targeting

We continuously analyze the behavior of those who did, and didn’t register, for trials to target patients with similar behaviors to boost conversions and improve ROI.

Special screening techniques

Our targeting techniques drive high volumes of traffic to our customized screeners, leading to higher numbers of referred and randomized patients for asthma studies. For example, one campaign drove 900k+ visits to our ClinLife trial-specific landing pages.

Given varying epidemiological definitions of asthma, we develop personalized screeners for your study consisting of multiple questions assessing medical eligibility, including I/E criteria, diagnosis, and symptoms.

Ensuring a high scheduling rate, we also provide a customized phone screener that covers participation willingness and a detailed assessment of medication history. This helps to limit study delays and ensures more consented and randomized patients.

Find patients aligned to your protocol

Asthma is a heterogeneous condition presenting with many phenotypes. Importantly, age of onset appears to play a key role in patient health. Although asthma is among the most common chronic diseases in children, adults with asthma experience higher morbidity and mortality than children.

We are able to actively reach both children and adults for clinical trials. For example, the youngest patient enrolled in a trial was 4 years old, while the oldest was 80 years old.

Our Chief Medical Officer reviews your protocol and aligns with our patient recruitment team. We develop and create objectives and tactics to ensure that patients referred to your sites fit the exact requirements of your study.

Addressing patient diversity in asthma trials

Minority groups are underrepresented in asthma clinical trials – despite evidence that these individuals are interested in participating in studies. A lack of diversity in asthma research limits progress towards improved healthcare and treatment options. Clinical trials will have greater success with recruiting patients by addressing uncertainty among patients, increasing flexibility of study and intervention protocols, and engaging with underrepresented communities.

Informed by Patient Insights, our asthma patient recruitment and retention services allow us to reach a more diverse patient population. We use digital tools and multiple communication channels to reduce physical barriers to site access, create patient-friendly study materials to increase health literacy, and tailor strategies to local communities and cultures.

By understanding patient needs, we can overcome the unique barriers these patients face when joining clinical trials.

Leveraging decentralized solutions in your asthma studies

Embracing new decentralized clinical trial (DCT) solutions can help your clinical trial stay on track and reduce patient drop-out. For example, remote sensing devices enables continuous real-world data collection of asthma symptoms and asthma attacks, while electronic patient diaries allows patients to easily record their daily symptoms.

We can help you adopt new approaches and transform your trial by navigating regulatory changes, creating study materials for patients and caregivers to better understand new technologies, and providing intensified support to sites to reduce site burden.

Our experience with hybrid and DCTs can be applied directly to your study.

Are you designing an asthma study, or have one underway?

We can help you find the right patients, at the right time. To find out more, contact us.